Medicare Enrolled

Dr. Karin Bigman, M.D.

Medical Oncology · Daytona Beach, FL
Practice pattern: Mixed Practice — Diverse clinical practice across multiple procedure types
Low-engagement
224 MEMORIAL MEDICAL PKWY, Daytona Beach, FL 32117
3862314060
In practice since 2006 (19 years)
NPI: 1285690529 verify on NPPES ↗
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating. This page presents federal public records about Dr. Bigman from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Bigman? Request a correction or review of any data shown here. Provider portal →

What this data tells you about Dr. Bigman

Dr. Karin Bigman is a medical oncology specialist in Daytona Beach, FL, with 19 years of NPI registration. Based on federal Medicare data, Dr. Bigman performed 24,284 Medicare services across 980 unique beneficiaries.

Between the years covered by Open Payments, Dr. Bigman received a total of $2,875 from 58 pharmaceutical and/or device companies across 160 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in medical oncology. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.

The Data Coverage level for Dr. Bigman is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.

✓ 19 years in practice ▲ Top 41% volume in FL $2,875 industry payments

Medicare Practice Summary

Medicare Utilization ↗
24,284
Medicare services
Top 41% in FL for medical oncology
980
Unique beneficiaries
$5
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~1,278 Medicare services per year of practice

Top procedures by volume

Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.

Procedure Volume Avg. paid Avg. submitted
Iron infusion (Feraheme) 19,380 $0 $4
Denosumab injection (Prolia/Xgeva) 2,640 $18 $51
Complete blood count (CBC) with differential 500 $8 $29
Blood draw (venipuncture) 440 $8 $9
Office visit, established patient (30-39 min) 305 $91 $339
Drug injection, under skin or into muscle 280 $10 $69
Injection, vitamin b-12 cyanocobalamin, up to 1000 mcg 187 $1 $6
Injection of additional new drug or substance into vein 137 $12 $61
Administration of chemotherapy into vein, 1 hour or less 97 $97 $378
Infusion into a vein for therapy, prevention, or diagnosis, 1 hour or less 58 $48 $189
Initial hospital admission, high complexity 54 $137 $556
Injection, methylprednisolone sodium succinate, up to 40 mg 42 $3 $11
Injection of drug or substance into vein 38 $28 $156
Office visit, established patient, complex (40-54 min) 38 $138 $474
Infusion into a vein for therapy, prevention, or diagnosis, additional sequential infusion, 1 hour or less 36 $22 $84
New patient office visit (45-59 min) 18 $112 $453
Office or other outpatient visit for the evaluation and management of established patient that may not require presence of healthcare professional 17 $16 $59
Hospital follow-up visit, high complexity 17 $94 $285
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
80.2% high complexity
14.1% medium
5.7% routine

Industry Payment Transparency

Open Payments through 2024 ↗
$2,875
Total received (2018-2024)
Avg $411/year across 7 years
Bottom 35% in FL for medical oncology
58
Companies
160
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →

Payment profile

Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.

Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$2,847 (99.0%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$28 (1.0%)

Payment trend by year

Annual totals from pharmaceutical and medical device companies.

2024
$617
2023
$881
2022
$443
2021
$17
2020
$117
2019
$405
2018
$395

Payments by company (2024)

Consulting
Speaking
Meals & Travel
Research
Novartis Pharmaceuticals Corporation
$276
Celgene Corporation
$227
BeiGene USA, Inc.
$143
Janssen Biotech, Inc.
$134
Merck Sharp & Dohme Corporation
$123
Incyte Corporation
$120
Eisai Inc.
$114
AstraZeneca Pharmaceuticals LP
$111
Amgen Inc.
$105
Kite Pharma, Inc.
$88
PFIZER INC.
$87
Merck Sharp & Dohme LLC
$67
TAIHO ONCOLOGY, INC.
$61
Ipsen Biopharmaceuticals, Inc
$60
Daiichi Sankyo Inc.
$56
Bayer HealthCare Pharmaceuticals Inc.
$55
EMD Serono, Inc.
$51
Gilead Sciences, Inc.
$51
Foundation Medicine, Inc.
$48
ARRAY BIOPHARMA INC
$40
Seagen Inc.
$38
Lilly USA, LLC
$37
Genentech USA, Inc.
$36
Regeneron Healthcare Solutions, Inc.
$35
Stemline Therapeutics Inc.
$29
JAZZ PHARMACEUTICALS INC.
$29
AMAG Pharmaceuticals, Inc.
$28
Alexion Pharmaceuticals, Inc.
$28
E.R. Squibb & Sons, L.L.C.
$27
Aurobindo Pharma USA, Inc.
$26
MEDIVATION FIELD SOLUTIONS LLC
$26
Rigel Pharmaceuticals, Inc.
$25
NanoString Technologies, Inc.
$24
Pharmacosmos Therapeutics Inc.
$24
Pharmacyclics LLC, An AbbVie Company
$23
SANOFI-AVENTIS U.S. LLC
$23
Lexicon Pharmaceuticals, Inc.
$23
ABBVIE INC.
$22
Astellas Pharma US Inc
$22
Mirati Therapeutics, Inc.
$22
Bayer Healthcare Pharmaceuticals Inc.
$21
AbbVie Inc.
$21
Seattle Genetics, Inc.
$20
Boehringer Ingelheim Pharmaceuticals, Inc.
$19
Emmaus Medical, Inc.
$18
Exelixis Inc.
$18
TESARO, Inc.
$18
PharmaEssentia USA Corporation
$18
MorphoSys, US Inc.
$18
R-Pharm US LLC
$17
G1 Therapeutics, Inc.
$17
CSL Behring
$17
Coherus Biosciences Inc.
$17
TerSera Therapeutics LLC
$16
Taiho Oncology, Inc.
$14
CTI BioPharma Corp.
$14
Puma Biotechnology, Inc.
$14
Janssen Pharmaceuticals, Inc
$12
Top 3 companies account for 22.5% of total payments
Associated products mentioned in payments ›
ADCETRIS · Afstyla · Avastin · BESREMI · BRAFTOVI · BRUKINSA · Bavencio · CABOMETYX · CALQUENCE · COSELA · DARZALEX · ENHERTU · EPKINLY · ERLEADA · Endari · Enhertu · FERAHEME · FOUNDATIONONE · Folotyn · GILOTRIF · Halaven · IMBRUVICA · IMFINZI · INJECTAFER · INLYTA · Ixempra · JAKAFI · JEVTANA · KEYTRUDA · KISQALI · KRAZATI · Kyprolis · LIBTAYO · LONSURF · LUMAKRAS · Lenvima · Lonsurf · MEKINIST · MONJUVI · MONOFERRIC · NERLYNX · Nubeqa · OPDIVO · OPDUALAG · Onivyde · Orserdu · PIQRAY · PROMACTA · PROSIGNA ASSAY · Perjeta · Pomalyst · REBLOZYL · RYBREVANT · Revlimid · SCEMBLIX · SOMATULINE DEPOT · SUTENT · Somatuline Depot · Stivarga · TASIGNA · TIVDAK · Tavalisse · Trodelvy · ULTOMIRIS · Udenyca · VENCLEXTA · VERZENIO · Vonjo · XALKORI · XARELTO · XTANDI · Xermelo · Xospata · ZEJULA · ZEPZELCA · Zevalin · Zoladex
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →

Most payments (99%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.

Equivalent to $12 per 100 Medicare services performed
Looking for a medical oncology specialist in Daytona Beach?
Compare medical oncologists in the Daytona Beach area by procedure volume, costs, and industry payment transparency.
Browse medical oncologists nearby

Geographic Context

Medical oncologists within 10 mi
8
Per 100K population
1.4
County median income
$66,581
Nearest hospital
ADVENTHEALTH DAYTONA BEACH
0.0 mi

Data Sources

Provider Registry NPPES Weekly updates
Medicare Enrollment PECOS Monthly updates
Practice Data Medicare Util. Annual (CY lag)
Industry Payments Open Payments CY 2024
Disciplinary History — Not public N/A

This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →

Summary

Dr. Bigman is a mixed practice specialist, with moderate Medicare volume, with low-engagement industry engagement, with 19 years of NPI registration.

This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →

Frequently Asked Questions

Is Dr. Bigman experienced with iron infusion (feraheme)?
Based on Medicare claims data, Dr. Bigman performed 19,380 iron infusion (feraheme) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Bigman receive payments from pharmaceutical companies?
Yes. Dr. Bigman received a total of $2,875 from 58 companies across 160 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Bigman's costs compare to other medical oncologists in Daytona Beach?
Dr. Bigman's average Medicare payment per service is $5. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Bigman) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
About this page

All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.

This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.

Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology

Data Disclaimer — Data sourced from the Centers for Medicare & Medicaid Services (CMS): National Plan and Provider Enumeration System (NPPES), Open Payments program, Medicare Provider Utilization and Payment Data, and Provider Enrollment & Certification data (PECOS). Published under the Freedom of Information Act (FOIA). This website is not affiliated with, endorsed by, or authorized by CMS, HHS, or the U.S. Government. Data may contain errors as reported to CMS by providers and reporting entities. Payments from industry are legal and do not indicate wrongdoing. Medicare data reflects only patients aged 65+ or those with qualifying disabilities. For corrections, contact CMS directly. This information does not constitute medical advice and should not be used as the sole basis for choosing a healthcare provider. Procedure descriptions use plain language and do not reference CPT® codes, which are copyrighted by the American Medical Association. Full methodology → · Report a data error → · Privacy policy →